Privi Speciality Chemicals Ltd (NSE:PRIVISCL)
₹ 2,432 +6.6 (+0.27%) Market Cap: 94.98 Bil Enterprise Value: 105.98 Bil PE Ratio: 50.79 PB Ratio: 8.61 GF Score: 71/100
Back to the Transcripts List

Q3 2025 Privi Speciality Chemicals Ltd Earnings Call Transcript

Feb 13, 2025 / 10:30 AM GMT
Release Date Price: ₹1623.3 (-3.04%)

Key Points

Positve
  • Privi Speciality Chemicals Ltd (BOM:530117) reported a 20% growth in total income for Q3, reaching INR 493 crores.
  • EBITDA grew by 20% with margins standing at 23%, indicating strong operational efficiency.
  • The company has secured 70% of its business through contracts with large multinational companies, providing revenue visibility.
  • Significant demand for flagship products has led to capacity enhancements, which are expected to drive future growth.
  • Privi Speciality Chemicals Ltd (BOM:530117) is focusing on sustainability, with improvements in CDP project scores and increased use of green power.
Negative
  • A planned shutdown for capacity enhancement resulted in slightly lower revenue for Q3 compared to Q2.
  • There was a temporary increase in other expenses due to air freight costs, impacting overall expenses.
  • The company faces challenges in the North American market, with a year-on-year decline in business.
  • The process of entering the pharmaceutical market is lengthy, with regulatory compliance and certifications still in progress.
  • The company is operating at high capacity utilization, necessitating further CapEx for future growth, which may increase debt levels.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PIVI.NS - Privi Speciality Chemicals Ltd
Q3 2025 Privi Speciality Chemicals Ltd Earnings Call
Feb 13, 2025 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Q3 and 9 months FY25 conference call of Privy Specialty Chemicals Limited.

This conference may contain forward-looking statements about the company which are based on the beliefs, opinions, and expectations of the company as on date of this call. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing, then 0 on your
Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.